CSF2 and prostate carcinoma: The GM-CSF gene-transduced prostate cancer cells have been studied to evaluate the clinical effect of combining this potent cytokine with killed tumor cells (GVAX) that have multiple tumor-associated antigens to which the immune system can make a response.